IDEX Biometrics ASA (the “Company”) refers to its stock exchange announcement on 30 April 2025 regarding notice of an annual general meeting scheduled for 21 May 2025 (the “AGM”). In accordance with Section 6-16b of the Public Limited Liability Companies Act, the Board has prepared a report on the salary and other remuneration of executive management of the Company in 2024 (“Remuneration Report”), and the Company’s auditors have issued an assurance report in relation to such Remuneration Report, both of whi ...

Reference is made to the announcement by IDEX Biometrics ASA on 5 May 2025 regarding the results of the exercise of Warrants B. A total of 36,767 Warrants B were exercised, resulting in an aggregate subscription for 36,767 new shares, each Warrant B having an exercise price of NOK 0.15. The share capital increase has duly been registered in the Norwegian Register of Business Enterprises. Following the share capital increase, the company's share capital will be NOK 38,316,309.99, divided into 3,831,630,999 s ...

Reference is made to the announcement by IDEX Biometrics ASA (the "Company") on 12 December 2024 regarding the listing of Warrants A and Warrants B on Oslo Stock Exchange. Warrants B were exercisable between 31 March 2025 and 11 April 2025, and all Warrants B not exercised within such time lapsed without compensation to the holder. A total of 36,767 Warrants B were exercised, resulting in an aggregate subscription for 36,767 new shares (the "New Shares") in the Company, each Warrant B having an exercise pri ...

IDEX Biometrics ASA will hold its 2025 annual general meeting on Wednesday 21 May 2025 at 14.00 hours CET as an online meeting. There is no physical attendance option. Shareholders may attend online by PC, smartphone or tablet. The notice with attendance form has been sent to the shareholders today, and is also enclosed. The notice of the annual general meeting and the ancillary documents are also available at the company's web site, www.idexbiometrics.com , and can be requested from the company at no charg ...

Reference is made to the announcement by IDEX Biometrics ASA (the "Company") on 11 March 2025 regarding a loan financing of NOK 30 million and a proposed debt conversion of the loan. Reference is also made to the announcement on 11 April 2025 regarding the resolution by the Extraordinary General Meeting to carry out the debt conversion by issuance of a total of 3,000,000,000 new shares in the Company. The share capital increase by debt conversion has duly been registered in the Norwegian Register of Busines ...

Reference is made to the share capital reduction in IDEX Biometrics ASA (the “Company”) resolved by the extraordinary general meeting on 11 April 2025, agenda item 3. The share capital reduction by reduction of the par value of the shares in the Company has been registered. Following the registration, the Company's share capital is NOK 8,315,942.32 divided into 831,594,232 shares, each with a nominal value of NOK 0.01. For further information contact: Marianne Bøe, Head of Investor Relations, Tel: +47 91800 ...

文章核心观点 公司对2025年4月14日大股东持股公告中的错误进行更正，并披露相关股东持股情况 [1] 分组1：公司股份变动情况 - 2025年4月11日公司特别股东大会决议在减资登记后进行债转股发行30亿股 使公司股份增至38.31594232亿股 [2] 分组2：股东持股情况 - 罗伯特·基思的密切关联方查尔斯街国际有限公司在减资登记后将获配10亿股债转股股份 持股比例达26.10% [3] - 罗伯特·基思及其密切关联方在减资登记后将持有1.087395479亿股 占公司股份和表决权的28.38% [4]

IDEX Biometrics ASA discloses the following on behalf of a shareholder. Reference is made to the notice by IDEX Biometrics on 11 April 2025 that the Extraordinary General Meeting of the company had, subject to the registration of a share capital reduction, resolved to issue 3,000,000,000 shares in a debt conversion, thereby increasing the number of shares in the company to 3,831,594,232. Altea AS will, subject to the registration of the share capital reduction, be allocated 287,500,000 shares in the debt ...

文章核心观点 公司公布主要内幕交易情况并提供联系方式 [1] 分组1 - 公司公布主要内幕交易信息，详情见附件 [1] - 投资者关系负责人为Marianne Bøe，电话+47 91800186；首席财务官为Kristian Flaten，电话+47 95092322；邮箱为ir@idexbiometrics.com [1] 分组2 - 附件显示2025年4月11日，董事长Morten Opstad和首席执行官Anders Storbraten为主要内幕人员 [2]

文章核心观点 公司2025年4月11日特别股东大会批准所有提案决议，包括股份合并及ISIN变更相关事宜 [1] 股份合并信息 - 股份合并条款公布日期为2025年4月11日 [1] - 股份合并比例为100股旧股换1股新股 [1] - 含权最后一日为2025年6月10日 [1] - 除权日为2025年6月11日 [1] - 登记日为2025年6月12日 [1] - 批准日期为2025年4月11日 [1] ISIN变更信息 - 发行人是IDEX Biometrics ASA [1] - 旧ISIN为NO0013107490 [1] - 新ISIN为NO0013536078 [1] - ISIN变更日期为2025年6月11日 [1] 公司信息 - 公司是全球指纹生物识别技术领导者，提供支付、访问控制和数字身份认证解决方案 [2] - 公司解决方案基于专利和专有传感器技术、集成电路设计和软件，针对基于卡的支付和数字认证应用 [2] - 公司作为行业推动者，与领先卡制造商和科技公司合作将解决方案推向市场 [2] 联系方式 - 投资者关系主管Marianne Bøe，电话+47 91800186 [2] - 首席财务官Kristian Flaten，电话+47 95092322 [2] - 邮箱ir@idexbiometrics.com [2] - 网址www.idexbiometrics.com [3] 公告信息 - 公告由首席财务官Kristian Flaten于2025年4月11日16:50 CET代表公司发布 [3] - 信息需遵守挪威证券交易法第5 - 12条和奥斯陆证券交易所规则手册披露要求 [3]